Skip to content Skip to footer
Subscribe Now
 Mayne Pharma
NEWS

Cosette Pharmaceuticals to Acquire Mayne Pharma for ~$430M

Shots: Cosette Pharmaceuticals to acquire Mayne Pharma Group for ~$430M, with shareholders receiving $4.71/share. Closing expected in Q2’25 Acquisition will strengthen Cosette’s dermatology & women’s health business, adding 12 patent-protected products incl. Vyleesi, Intrarosa, Nextstellis, Annovera, Bijuva, Imvexxy, & Rhofade along with multiple pipeline candidates in its product line upon closing The combined…
February 21, 2025

Read more

NEWS

Hologic Completes the Acquisition of Gynesonics for ~$350M

Shots: Hologic has completed the acquisition of Gynesonics, focused on developing minimally invasive women’s health solutions, for ~$350M The acquisition has strengthened Hologic's portfolio with the addition of Sonata System, a minimally invasive solution for heavy periods & fibroids The Sonata System is developed to capture intrauterine images for diagnosis and transcervical treatment…
January 7, 2025

Read more

VIEWPOINTS_Amy Taneja_2023
VIEWPOINTS

Women Health: Amy Taneja in a Striking Conversation with PharmaShots Shares the Highlights of Jada System

Shots:  Amy Taneja, in a stimulating conversation with PharmaShots, shares the highlights of the Jada system, a vacuum-induced hemorrhage control device   Amy describes how the Jada system differs from traditional methods of controlling PPH while explaining how the system works   JADA, which is now being shipped to Chile, Hong Kong, Puerto Rico, New Zealand, and…
December 26, 2023

Read more

PharmaShots Magazine-November 2023 Edition
MAGAZINE

PharmaShots Magazine-November 2023 Edition

Health is not a commodity, it’s an indispensable human right that must know no boundary of gender, race, or socio-economic status. Health for all is an all-inclusive mission by the WHO that aims to reduce preventable mortalities and morbidities by providing healthcare provisions in every area. Women health is still a concerning topic in under-developed and…
November 10, 2023

Read more